Literature DB >> 22484638

Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.

N Rawat1, A Alhamdani, E McAdam, J Cronin, Z Eltahir, P Lewis, P Griffiths, J N Baxter, G J S Jenkins.   

Abstract

INTRODUCTION: Curcumin has been suggested to possess anti-neoplastic properties. As oesophageal adenocarcinoma (OA) and Barrett's oesophagus (BO) represent a neoplastic series, we postulated that curcumin supplementation may slow neoplastic progression at this site. Our aim was to investigate the effects of curcumin in vitro and in vivo on markers of oesophageal cancer progression.
METHODS: We investigated the in vitro ability of curcumin to prevent bile acid-induced DNA damage using micronucleus assay and nuclear factor-kappaB (NF-κB) activity in the oesophageal cell lines (OE33) using real-time PCR of the extracted RNA. We also analysed NF-κB p65 activation in curcumin-pre-treated OE33 cells exposed to deoxycholic acid (DCA) using ELISA. In another pilot study, BO patients took a daily 500 mg curcumin tablet for 7 days prior to their endoscopy. In biopsies collected from these patients (n=33, 16 curcumin, 17 control), we examined NF-κB-driven gene expression (interleukin (IL)-8, inhibitor- kappaB (I-κB)) using real-time PCR of the extracted RNA from the biopsy sample. The apoptotic frequency was assessed by counting the number of apoptotic bodies in the epithelial cells from the Barrett's tissue with and without curcumin.
RESULTS: In vitro, curcumin (50 μM) significantly abrogated DNA damage and NF-κB activity induced by bile. Pretreating OE33 cells with curcumin (50 μM) completely abolished the ability of DCA (300 μM) to activate NF-κB. In vivo, IL-8 expression was non-significantly suppressed in the curcumin-supplemented patients compared to the squamous control tissue, whilst also showing a doubling in the apoptotic frequency compared to non-supplemented control patients.
CONCLUSIONS: Curcumin abrogated bile-driven effects in vitro. The in vivo data also suggests that curcumin supplementation had beneficial effects (increased apoptosis, potentially reduced NF-κB activity) in the Barrett's tissues themselves, despite poor delivery of the curcumin to the oesophagus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484638     DOI: 10.1007/s12094-012-0799-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  61 in total

1.  Diet and risk of esophageal cancer by histologic type in a low-risk population.

Authors:  A Tzonou; L Lipworth; A Garidou; L B Signorello; P Lagiou; C Hsieh; D Trichopoulos
Journal:  Int J Cancer       Date:  1996-11-04       Impact factor: 7.396

2.  Antioxidants and cancers of the esophagus and gastric cardia.

Authors:  P Terry; J Lagergren; W Ye; O Nyrén; A Wolk
Journal:  Int J Cancer       Date:  2000-09-01       Impact factor: 7.396

Review 3.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

4.  Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring.

Authors:  L Liu; G Ergun; A Ertan; K Woods; I Sachs; M Younes
Journal:  Aliment Pharmacol Ther       Date:  2003-10-01       Impact factor: 8.171

5.  Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.

Authors:  Kathy Hormi-Carver; Xi Zhang; Hui Ying Zhang; Robert H Whitehead; Lance S Terada; Stuart J Spechler; Rhonda F Souza
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.

Authors:  M T Huang; T Lysz; T Ferraro; T F Abidi; J D Laskin; A H Conney
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

7.  Effect of curcuma on radiation-induced apoptosis in human cancer cells.

Authors:  S Baatout; H Derradji; P Jacquet; D Ooms; A Michaux; M Mergeay
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

Review 8.  Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.

Authors:  Christopher P Wild; Laura J Hardie
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

9.  Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus.

Authors:  P Gillen; P Keeling; P J Byrne; M Healy; R R O'Moore; T P Hennessy
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

10.  Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

Authors:  C J van der Woude; P L M Jansen; A T G M Tiebosch; A Beuving; M Homan; J H Kleibeuker; H Moshage
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

View more
  8 in total

1.  Effects of PDTC on NF-κB expression and apoptosis in rats with severe acute pancreatitis-associated lung injury.

Authors:  Shihai Kan; Hongying Zhou; Changzhu Jin; Huijun Yang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway.

Authors:  Zhigang Guo; Han Wang; Jun Wei; Liang Han; Zhaohui Li
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

Review 3.  Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development.

Authors:  Min-Yu Chung; Tae Gyu Lim; Ki Won Lee
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

4.  Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.

Authors:  Junmin Zhou; Sarah S Donatelli; Danielle L Gilvary; Melba M Tejera; Erika A Eksioglu; Xianghong Chen; Domenico Coppola; Sheng Wei; Julie Y Djeu
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

Review 5.  The multifaceted role of curcumin in cancer prevention and treatment.

Authors:  Muthu K Shanmugam; Grishma Rane; Madhu Mathi Kanchi; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Benny K H Tan; Alan Prem Kumar; Gautam Sethi
Journal:  Molecules       Date:  2015-02-05       Impact factor: 4.411

Review 6.  Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment.

Authors:  Gregory A Plotnikoff
Journal:  Glob Adv Health Med       Date:  2014-05

7.  Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.

Authors:  Xuan Ni; Yimeng Gao; Zhitao Wu; Leilei Ma; Chen Chen; Le Wang; Yunfei Lin; Lijian Hui; Guoyu Pan
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

Review 8.  Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers.

Authors:  Carmen Tse; Ashleigh Warner; Rufaik Farook; James G Cronin
Journal:  Biomolecules       Date:  2020-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.